Skip to content

Effect of remifentanil combined with dexmedetomidine on postoperative sleep quality in patients undergoing thoracoscopic lobectomy

Effect of remifentanil combined with dexmedetomidine on postoperative sleep quality in patients undergoing thoracoscopic lobectomy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034724
Enrollment
Unknown
Registered
2020-07-16
Start date
2020-08-01
Completion date
Unknown
Last updated
2020-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep disorders after thoracoscopic lobectomy

Interventions

Sufentanil + dexmedetomidine group:Application of Sufentanil combined with dexmedetomidine and tropisetron for postoperative patient-controlled analgesia
Remifentanil + dexmedetomidine group:Application of remifentanil combined with dexmedetomidine and tropisetron for postoperative patient-controlled analgesia

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) The patients who were scheduled for VATS lobectomy; (2) Aged 18-75 years; (3) American Association of anesthesiologists (ASA) grade I-II, BMI 18.5 kg / m2-28 kg / m2; (4) Patients agreed to receive PCIA.

Exclusion criteria

Exclusion criteria: (1) Pittsburgh sleep quality index score > 7; (2) patients with myasthenia gravis and respiratory depression; (3) patients with bronchial asthma; (4) patients receiving long-term anesthesia, analgesia, sedation or non steroidal anti-inflammatory drugs; (5) patients with sinus bradycardia (heart rate less than 50 beats) before operation; (6) long term use of anticonvulsant drugs, antidepressants or other psychotropic drugs; (7) taking monoamine oxidase inhibitors and allergic to the drugs in this study. (8) Severe heart, liver or kidney diseases; (9) participated in other clinical trials in the past 3 months; (10) had hearing and language communication barriers, and could not communicate effectively with doctors.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative sleep disorders;

Secondary

MeasureTime frame
Ramsay score;The score of Athens Insomnia Scale;Resting and motor visual analogue (VAS) scores;Hospital Anxiety and Depression Scale score;;The times of effective compressions obtained from PCIA device within 48 hours after operation, and the demand for analgesic drugs was remedied;

Countries

China

Contacts

Public ContactCheng Wei

Department of Anesthesiology, Affiliated Hospital of Xuzhou Medical University

53974314@qq.com+86 18796205791

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026